AVEO News and Press, AVEO Pharmaceuticals Inc. From 10/19/22

NEW YORK, NY / ACCESSWIRE / October 19, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: AVEO Pharmaceuticals, Inc. (NASDA...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/zimmytws Zovio (NASDAQ: ZVO ) stock is rocketing higher on Tuesday as investors prepare for an incredibly important vote next week! Zovio will hold a shareholder meeting on Oct. 25 t...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: photo-lime / Shutterstock.com Ra Medical (NYSEMKT: RMED ) stock is rocketing higher on Tuesday after the medical device company raised $7.6 million . This comes from an at-the-market (ATM) facility th...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time for another look at the biggest pre-market stock movers as we check out what’s happening Tuesday morning! Moving stocks this morning are heavy trading, acqui...

LG Chem ( OTCPK:LGCLF ) will acquire AVEO for $15.00 per share in an all-cash transaction with an implied equity value of $566M on a fully diluted basis. Upon completion of the transaction, AVEO will operate as the U.S. commercial foundation for LG Chem Life Sciencesȁ...

Acquisition Provides LG Chem’s Life Sciences Division a Commercial Footprint in the U.S., Diversifies its Pipeline with a Broad Range of Oncology Therapies and Accelerates LG Chem’s Efforts to Deliver Continued Growth AVEO Will Have Enhanced Ability to Deliver on i...

BOSTON, Oct. 12, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, announced today that, as disclosed on uspto.gov, the United States Pa...

BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, today announced that Michael Bailey, president and chief executive o...

BOSTON, Aug. 31, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, today announced that members of its senior management team are schedu...

Today, we put small oncology name AVEO Pharmaceuticals in the spotlight for the first time in three and a half years. The company is seeing good sales growth from its franchise drug that was approved in 2021 and is marching toward profitability as a company. An investment analysis...